Talk:C1-inhibitor

Physiology Mid‑importance

	This article is within the scope of WikiProject Physiology, a collaborative effort to improve the coverage of Physiology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PhysiologyWikipedia:WikiProject PhysiologyTemplate:WikiProject PhysiologyPhysiology
Mid	This article has been rated as Mid-importance on the importance scale.
	This article has been classified as relating to blood.

Molecular Biology: MCB

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
Mid	This article has been rated as Mid-importance on the project's importance scale.

Assessment comment

The comment(s) below were originally left at Talk:C1-inhibitor/Comments, and are posted here for posterity. Following several discussions in past years, these subpages are now deprecated. The comments may be irrelevant or outdated; if so, please feel free to remove this section.

Comment(s)

Press [show] to view →

General remarks:

- Synonyms for C1-inhibitor should be included, as many exists.

- An additional figure is suggested: schematic representation of C1-inh, showing secondary structure elements in primary sequence. This is also suggested for other protein articles, too.

- The database informations should be shortened and cleaned up. Many are ambiguous and irrelevant, and even dead links exists.

- Unbalanced text. Too much emphasis on therapy, less on functional and molecular aspects. It should be extended considerably, by explaining the mechanism of HAE, and other potential activities unrelated of preoteinase inhibition.

- Error: it is told, that C1-inh is impossible to produce recombinantly. C1-inh was produced in mammalian, baculovirus, and yes, even in E. coli systems (although almost non-existent activity). Another highly effective system is yeast (Pichia pastoris).

- Highly irrelevant external links. Should be deleted or explained, and other links added.

- Only a single biased citation exists to credible information. This must be changed, to include original research papers presenting direct experimental work.

Maybe I will contribute in the near future.

Regards,

pl_denton

Last edited at 13:51, 4 May 2007 (UTC). Substituted at 10:38, 29 April 2016 (UTC)